With the introduction of the SUPR, Getinge again exploits its experience in bioreactor design resulting in a single-use bioreactor system for pilot and GMP manufacturing applications, completely scalable from its’… Read More
VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (Cboe CA:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, announced the appointment of Michael Messinger, CPA, to its Board of… Read More
Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints Expects two more Phase 3 readouts in 2024, including combination vaccine against flu and… Read More
Canada’s largest biotechnology company expands further into cancer diagnostic market with novel in vitro diagnostic medical device VANCOUVER, BC – STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone… Read More
Gilead Granted Exclusive License to Xilio’s Tumor-Activated IL-12 Program, Including XTX301, a Clinical-Stage IL-12 Molecule with Potential to Treat a Broad Range of Cancers FOSTER CITY, CA & WALTHAM, MA… Read More
